BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04422912-completion@plaintrial.com
DTSTAMP:20261027T210106Z
DTSTART;VALUE=DATE:202901
SUMMARY:A Phase 1/2\, Open-label\, Safety and Dosing Study of Autologous CA
 RT Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART]
  or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subject
 s With Active\, Pemphigus Vulgaris (RESET-PV) — estimated completion dat
 e
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04422912
URL:https://plaintrial.com/trial/NCT04422912
END:VEVENT
END:VCALENDAR